Several growth factors, such as transforming growth factor beta (TGFβ) (5), connective tissue growth factor (CTGF) (6) and platelet-derived growth factor (PDGF), can activate the profibrotic response of fibroblasts and thus contribute to the pathogenesis of SSc (7). The gene discussed is CCN2; the disease is systemic sclerosis.